Zhengye Biotechnology Holding (ZYBT) Enterprise Value: 2023-2025
- Zhengye Biotechnology Holding's Enterprise Value was N/A to $284.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $9.1 million, marking a year-over-year change of. This contributed to the annual value of $6.8 million for FY2024, which is 22.45% up from last year.
- According to the latest figures from Q2 2025, Zhengye Biotechnology Holding's Enterprise Value is $284.4 million, which was up 4,175.79% from $6.7 million recorded in Q4 2024.
- In the past 5 years, Zhengye Biotechnology Holding's Enterprise Value registered a high of $284.4 million during Q2 2025, and its lowest value of $5.4 million during Q4 2023.
- Its 3-year average for Enterprise Value is $98.8 million, with a median of $6.7 million in 2024.
- Data for Zhengye Biotechnology Holding's Enterprise Value shows a peak YoY climbed of 22.07% (in 2024) over the last 5 years.
- Over the past 3 years, Zhengye Biotechnology Holding's Enterprise Value (Quarterly) stood at $5.4 million in 2023, then rose by 22.07% to $6.7 million in 2024, then reached $284.4 million in 2025.
- Its Enterprise Value was $284.4 million in Q2 2025, compared to $6.7 million in Q4 2024 and $5.4 million in Q4 2023.
